is the generic ingredient in three branded drugs marketed by Warner Chilcott Llc
, Apotex Inc
, Mylan Pharms Inc
, Sun Pharma Global
, Teva Pharms
, and Teva Pharms Usa
, and is included in seven NDAs. There are ten patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.
This ingredient has sixty-six patent family members
in twenty-nine countries.
There are nineteen drug master file entries
for risedronate sodium. Four suppliers
are listed for this compound. There are five tentative approvals for this compound.